Evidence map›Paper›PMID 39245796›Full record

ArticleFEBS letters2024

Spontaneous and chaperone-assisted metal loading in the active site of protein phosphatase-1.

Gerd Van der Hoeven, Sarah Lemaire, Xinyu Cao, Zander Claes, Spyridoula Karamanou, Mathieu Bollen

Abstract read
In one paragraph

Article in FEBS letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gerd Van der HoevenLaboratory of Biosignaling & Therapeutics, KU Leuven Department of Cellular and Molecular Medicine, University of Leuven, Belgium.
Sarah LemaireLaboratory of Biosignaling & Therapeutics, KU Leuven Department of Cellular and Molecular Medicine, University of Leuven, Belgium.
Xinyu CaoLaboratory of Biosignaling & Therapeutics, KU Leuven Department of Cellular and Molecular Medicine, University of Leuven, Belgium.
Zander ClaesLaboratory of Biosignaling & Therapeutics, KU Leuven Department of Cellular and Molecular Medicine, University of Leuven, Belgium.
Spyridoula KaramanouLaboratory of Molecular Bacteriology, KU Leuven Department of Microbiology and Immunology, University of Leuven, Belgium.
Mathieu BollenLaboratory of Biosignaling & Therapeutics, KU Leuven Department of Cellular and Molecular Medicine, University of Leuven, Belgium.ORCID https://orcid.org/0000-0003-4975-1510

Funding

Fonds Wetenschappelijk Onderzoek G09092MKU Leuven Research Fund C14/20/101
6 · The paper itself

Abstract

Protein phosphatase PP1 has two active-site metals (Zn

Indexed as

Catalytic DomainMolecular ChaperonesProtein Phosphatase 1ZincHumansHydrogen-Ion ConcentrationIronManganeseIronManganeseMolecular ChaperonesProtein Phosphatase 1Zincmetal incorporationmetallo‐enzymePP1PPP1R11PPP1R2protein phosphataseRIPPO

Identifiers

PMID39245796
PMCPMC11626998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.